Thursday, 27.08.2026
09:00 – 09:45
Registration
Welcome Desk
Plenary 1
B Cells in Autoimmunity
Davide Robbiani, Bellinzona ; David Semela, St. Gallen
10:00–10:25
Discussion after presentation: 5 minute(s)
Antibody-selective treatment in autoimmunity
Harald Prüss, Berlin DE
10:30–10:55
Discussion after presentation: 5 minute(s)
B cells and autoimmunity
Claudia Mauri, London
11:00 – 11:30
Coffee Break
Plenary 2
T Cells in Tolerance and Immunity
Christian Münz, Zurich ; Magdalena Filipowicz, Basel
11:30–11:55
Discussion after presentation: 5 minute(s)
Checkpoint Inhibitor–Induced Hepatotoxicity: Diagnosis and Management
Eleonora de Martin, Paris FR
12:00–12:25
Discussion after presentation: 5 minute(s)
Peripheral immune tolerance mechanisms
Federica Sallusto, Bellinzona
12:30 – 14:00
Lunch Break
13:00–13:45
Anaphylaxis Today: From Patient Pathways to Clinical Practice
13:00 – 13:45
Room 4
Industry Symposium 2
Otsuka Pharmaceutical (Switzerland) GmbH, Glattbrugg
13:00–13:45
Personalising PBC Care in Daily Practice
Magdalena Filipowicz, Basel ; Andreas Kremer, Zürich; David Semela, St. Gallen
SSAI-AILD Parallel Session 1
Granulomatous Disease: Focus on Sarcoidosis
Massimiliano Fontana, Mendrisio ; Andreas Cerny, Lugano
14:00–14:22
Sarcoidosis: From a Pneumological Perspective
Katrin Hostettler Haack, Basel
14:22–14:44
Sarcoidosis: hepatological insights
Nasser Semmo, Bern
14:44–15:06
Sarcoidosis as a systemic disease – pitfalls and mimickers
Peter Korsten, Sendenhorst DE
15:06–15:28
Pathophysiology and actual treatment concepts in Macrophage activation syndrome / HLH
Klaus Tenbrock, Bern
SSAI-AILD Parallel Session 2
Acteria Awardees Session on Immunology and Allergy
Federica Sallusto, Bellinzona
14:00–14:25
Discussion after presentation: 5 minute(s)
Awardee 1
14:30–14:55
Discussion after presentation: 5 minute(s)
Awardee 2
15:00–15:25
Discussion after presentation: 5 minute(s)
How translational research can shape allergy management
Alexander Eggel, Bern
SSAI-AILD Parallel Session 3
Clinical Immunology
Camillo Ribi, Lausanne
14:00–14:25
Discussion after presentation: 5 minute(s)
ANCA-associated vasculitis: from autoantibodies to targeted treatments
Thomas Hauser, Zürich
14:30–14:55
Discussion after presentation: 5 minute(s)
Systemic lupus erythematosus: the role of B cells in pathogenesis and treatment
Camillo Ribi, Lausanne
15:00–15:25
Discussion after presentation: 5 minute(s)
IgG4-Related Disease: Pathophysiology, Diagnosis and Treatment
Jörg Seebach, Genève
SSAI-AILD Parallel Session 4
New Levels of Immune Regulation
Samuel P. Nobs, Lugano ; Mirjam Kolev,
14:00–14:25
Discussion after presentation: 5 minute(s)
Title to be defined
Christoph Hess, Basel
14:30–14:55
Discussion after presentation: 5 minute(s)
Mast cells as orchestrators of skin inflammation
Anne Dudeck, Magdeburg DE
15:00–15:25
Discussion after presentation: 5 minute(s)
The role of trained immunity in inflammation and cancer
Triantafyllos Chavakis, Dresden DE
15:30 – 16:00
Coffee Break
Hot Topics 1
Autoimmune Liver Disease
Antonio Galante, Lugano ; Christine Bernsmeier, Basel
16:00–16:18
Discussion after presentation: 5 minute(s)
Liver Malignancy Risk in Autoimmune Liver Diseases: Pathogenesis and Clinical Implications
Michael Heneghan, London
16:23–16:41
Discussion after presentation: 5 minute(s)
Variant Syndromes in 2026: New Insights and Evolving Concepts
Vincenzo Ronca, Milano IT
16:46–17:04
Discussion after presentation: 5 minute(s)
IgG4-Related Disease: From Diagnostic Dilemmas to Emerging Opportunities
Yoh Zen, London GB
17:09–17:27
Discussion after presentation: 5 minute(s)
Clinical management and surveillance in daily practice in PSC
Ulrich Beuers, Amsterdam NL
17:30 – 17:45
Room Change
AILD Research
Oral presentations on Autoimmune Liver Disease Research projects
17:45–18:07
Oral presentation 1
18:07–18:29
Oral presentation 2
18:29–18:51
Oral presentation 3
18:51–19:13
Oral presentation 4
17:45–18:30
Malattie autoimmune del fegato: gli esperti rispondono
Massimiliano Fontana, Mendrisio ; Antonio Galante, Lugano ; Mariangela Luzzi, Melide
18:30–19:00
Discussion after presentation: 5 minute(s)
Swiss HePa and patient organisation in Ticino
Claudia Rizzi, Locarno